SOFHOUR Finance SOFHOUR Finance
IPO desk
Sign in
Report a bugTell us what went wrong. We read every report.

What kind of problem?

We also send the page link and your browser name, to help us fix it.

Healthcare · NIFTY 500

Abbott India Limited

NSEABBOTINDIA ISININE358A01014 SeriesEQ Listed on NSE

₹26,555.00 +445.00 (+1.70%) Updated 12 Nov, 8:49 pm IST

Price, daily close-10.15% in a year

Today

Open
₹26,215.00
Prev close
₹26,110.00
Day high
₹26,795.00
Day low
₹26,130.00
Volume
9.4 K
Value traded
₹24.97 Cr
Upper circuit
₹31,330.00
Lower circuit
₹20,890.00
52W high
₹30,655.00
52W low
₹24,650.00
1 month
+3.13%
6 months
-5.09%
52W low52W high

Ratios

Key numbers

Worked out from the latest filings (Standalone) and today's price. TTM = last four quarters.

Market cap₹56,429 Cr
P/E (TTM)34.14
P/B13.21
Book value / share₹2,009.51
EPS (TTM)₹777.82
ROE38.7%
Dividend yield2.47%
Dividend (12m)₹656.00 / share
Net margin (TTM)23.0%
Operating margin29.1%
Debt / equity—
Current ratio2.76
EV / EBITDA27.32
Sales growth (YoY qtr)+11.03%
Profit growth (YoY qtr)+9.19%
Sales CAGR 3Y—
Profit CAGR 3Y—
Shares2.13 Cr

Quarterly results

Results for each quarter

Last 7 quarters, standalone, ₹ crore. Hover a bar to see the number.

Revenue and net profit

1,605367
Mar 25
1,738366
Jun 25
1,757415
Sep 25
1,724376
Dec 25
1,710395
Mar 26
1,814429
Jun 26
1,951453
Sep 26

Revenue · QoQ (vs last quarter)

—+8.3%+1.1%-1.9%-0.8%+6.1%+7.6%

Revenue · YoY (vs a year ago)

————+6.5%+4.3%+11%

Net profit · QoQ (vs last quarter)

—-0.3%+14%-9.5%+5.0%+8.5%+5.8%

Net profit · YoY (vs a year ago)

————+7.6%+17%+9.2%
RevenueNet profitLine = trend
172.72
Mar 25
172.17
Jun 25
195.42
Sep 25
176.92
Dec 25
185.85
Mar 26
201.66
Jun 26
213.39
Sep 26

EPS (₹) · YoY (vs a year ago)

————+7.6%+17%+9.2%
EPS (₹)Line = trend

Profit & loss

Results for each year

2 financial years (April to March), standalone, ₹ crore.

Sales, operating profit and net profit

6,4091,6951,414
FY25
6,9291,8921,552
FY26

Revenue · YoY (vs a year ago)

—+8.1%

Net profit · YoY (vs a year ago)

—+9.7%
RevenueOperating profitNet profitLine = trend

Balance sheet

Assets and debt

At each year end (and the latest half year), ₹ crore.

Equity, debt and assets

4,233561
Mar 25
4,774442
Mar 26
4,270837
Sep 26

Shareholders' equity · YoY (vs a year ago)

—+13%—
Shareholders' equityBorrowingsCashLine = trend

Cash flow

Cash coming in and going out

For each financial year, ₹ crore. Free cash flow = cash from operations minus spending on fixed assets.

Operating, investing and financing cash

1,012182-925
FY25
1,319-371-1,066
FY26

Operations · YoY (vs a year ago)

—+30%
OperationsInvestingFinancingLine = trend

Dividends & news

Latest dividends and announcements

Dividends & corporate actions

  • Dividend - Rs 525 Per Share & Special Dividend Rs 131 Per Share
  • Dividend - Rs 475 Per Share
  • Dividend - Rs 410 Per Share
  • Dividend - Rs 180 Per Share/ Special Dividend Rs 145 Per Share
  • Annual General Meeting/Dividend - Rs 145 Per Share/Special Dividend- 130 Per Share
  • Annual General Meeting/Dividend - Rs 120 Per Share Special Dividend 155 Per Share
  • Annual General Meeting/Dividend - Rs 107 Per Share And Special Dividend - Rs 143 Per Share
  • Annual General Meeting/ Final Dividend - Rs 50 Per Share/ Special Dividend - Rs 15 Per Share

Board meetings

No board meetings announced.

Filings with NSE

No recent filings.

About

About Abbott India Limited

Abbott India Limited is listed on the NSE under the symbol ABBOTINDIA and belongs to the Healthcare sector.

Company details

Company name
Abbott India Limited
NSE symbol
ABBOTINDIA
ISIN
INE358A01014
Listed on
NSE
Series
EQ (normal equity)
Listed on NSE since
8 Jan 2010
Face value
₹10 per share
Market lot
1 share
Shares issued
2.13 crore
Index
NIFTY 500
Sector (NSE)
Healthcare
Industry
Pharmaceuticals: Major
Managing director / CEO
Kartik Rajendran
Chair
Sudarshan Jain
Headquarters
Mumbai, IN
Founded
1944
Employees
3,749
Financial year
April to March
Results basis
Standalone

Peers

Other Healthcare stocks

Prices from NSE via Upstox. Financials from the company's results filed with BSE (XBRL); ratios are our own working. Profile from global-stock-logos (MIT). For information only, not a recommendation to buy or sell.